All-Oral Treatment of Newly Diagnosed Acute Myeloid Leukemia

Gail J. Roboz

Weill Cornell Medicine, New York Presbyterian Hospital, New York

Amer M. Zeidan

Gabriel N. Mannis

Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA

Pau Montesinos

Hospital Universitari i Politecnic La Fe, Valencia, Spain

Montserrat Arnan

Institut Català d’Oncologia, L’Hospitalet de Llobregat, Institut d’Investigació Biomèdica de Bellvitge, Universitat de Barcelona, Barcelona

Michael R. Savona

Department of Internal Medicine, Vanderbilt University School of Medicine

Olatoyosi Odenike

University of Chicago Medicine and Comprehensive Cancer Center, Chicago

James K. McCloskey

John Theurer Cancer Center, Hackensack Medical Center, Hackensack, NJ

Harshad V. Amin

Boca Raton Clinical Research, Boca Raton, FL

Amir T. Fathi

Massachusetts General Hospital Cancer Center–Harvard Medical School, Boston

Teresa Bernal del Castillo

Hospital Universitario Central de Asturias–Instituto Universitario del Principado de Asturias–Instituto Universitario de Oncología del Principado de Asturias, Oviedo, Spain

Gabriela Rodríguez-Macías

Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid

Jane L. Liesveld

Annie P. Im

University of Pittsburgh–UPMC Hillman Cancer Center, Pittsburgh

Jan Cerny

University of Massachusetts Chan Medical School–UMass Memorial Healthcare, Worcester

Teresa C. Gentile

State University of New York Upstate Medical University, Syracuse

Aram Oganesian

Taiho Oncology, Pleasanton, CA

Danna Chan

Taiho Oncology, Pleasanton, CA

Yubing Wan

Taiho Oncology, Pleasanton, CA

Margit Dijkstra

Taiho Oncology, Pleasanton, CA

Harold N. Keer

Taiho Oncology, Pleasanton, CA

Elizabeth A. Griffiths

Roswell Park Comprehensive Cancer Center, Buffalo, NY

Courtney D. DiNardo

Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas USA